Majidova, N. et al. 2025. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG). Turkish Journal of Gastroenterology. 36, 5 (Apr. 2025), 293–301. DOI:https://doi.org/10.5152/tjg.2025.24784.